skip to Main Content

Camena Bioscience closes $10m Series A financing as demand for DNA synthesis technology increases

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries.

© 2026 AccentBio. All Rights Reserved.
Site designed by Grid24 a division of Grid24 Ltd.

Back To Top